Advertisement
Worsening drug shortages leave providers scrambling for alternatives

Worsening drug shortages leave providers scrambling for alternatives

By Alex Kacik  |  May 21, 2018

Ninety-one percent of nearly 250 emergency physicians surveyed in a new ACEP poll said they had experienced a shortage or absence of critical medicine in their emergency department in the past month. That increases costs and compromises care.

Shorter breast cancer treatment could hurt providers' bottom line

Shorter breast cancer treatment could hurt providers' bottom line

By Alex Kacik  |  May 17, 2018

Women who use the breast cancer drug Herceptin for six months did just as well as those who took it for a year, according to a new study that could ultimately benefit value-based providers and harm those still based on fee-for-service models.

FDA explores requiring drug price disclosures in commercials

FDA explores requiring drug price disclosures in commercials

By Virgil Dickson  |  May 15, 2018

The FDA is exploring whether it can legally force drugmakers to disclose prices in consumer advertising. President Donald Trump has called the move a key strategy to give companies incentives to keep prices low.

Senate committee turns 340B spotlight on drugmakers

Senate committee turns 340B spotlight on drugmakers

By Susannah Luthi  |  May 15, 2018

The Senate health committee took hospitals out of the 340B hot seat to focus on pharmaceutical companies. Lawmakers wanted to know how much drugmakers may be overcharging 340B hospitals for discounted drugs.

Advertisement
kamagra gel

Delgra

суррогатная мать цена
X

Subscribe and SAVE 50%